Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 79Lymphoid 63Myeloid 49Plasma cell 29Classical hematology 23Sarcoma 15Dermatologic 9CNS 5Other neoplasm 4Gynecologic 2Breast 2Thoracic 1Other 1Genitourinary 1

Conditions

Thymoma 1Myelodysplastic Syndromes 1Leukemia 1Graft vs Host Disease 1Anemia, Refractory 1

Interventions

Azacitidine 3Polymerase Chain Reaction 2Counseling 2Bupropion 2tanespimycin 1sargramostim 1ruxolitinib 1rucaparib 1ribociclib 1pembrolizumab 1motexafin gadolinium 1incomplete Freund's adjuvant 1cc-486 1abiraterone 1Zinc Oxide 1Varenicline 1Uncertainty 1Tobacco Use Cessation Devices 1Tissue Banks 1Tinzaparin 1Radiotherapy 1Psychosocial Intervention 1Psychiatric Rehabilitation 1Paclitaxel 1Observation 1Nicotine Replacement Therapy 1Nicotine 1Methylprednisolone 1Melphalan 1Interleukin-15 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia × Melphalan × Thoracic × Clear all
NCT00003662 2011-03-07

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases

Roswell Park Cancer Institute

Phase 2 Completed
90 enrolled
Classical hematologyMyeloidOther hematologic neoplasmThoracic

Anemia, Refractory, Graft vs Host Disease, Leukemia, Myelodysplastic Syndromes, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡